T Lymphocytes are Cells that Scan the Surfaces of Other Cells {#S1}
=============================================================

A defining feature of T cells is their ability to become activated by pathogen-derived peptides presented on major histocompatibility complexes (pMHCs), while remaining quiescent when self-peptides are presented. Although *in vitro* experiments have successfully delineated the molecular requirements for TCR triggering and continue to serve as important experimental tool to analyze T cell activation, there is a factor that is difficult to reproduce in reductionist *in vitro* approaches: isolated naive T cells are typically immotile *in vitro* without prior activation, whereas these cells are remarkably motile *in vivo*. Direct observation of T cell behavior using intravital two photon microscopy (2PM) has shown that these cells have a polarized, amoeboid-like shape, and move in resting lymphoid tissue with speeds of \~12--15 μm/min, in an apparently random manner ([@B1]--[@B5]). Similarly, effector T cells in non-lymphoid tissues, including leptomeningeal membranes ([@B6]), liver ([@B7]), and pancreas ([@B8]), show continuous motility, although the tissue microarchitecture is likely to restrict T cell motility, in particular, in tightly packed epithelial layers of the skin ([@B9]). The dynamic motility has evolved because T cells are MHC restricted and therefore need to physically scan the surfaces of other cells. This process is balanced with rapid decision-making on whether to arrest (e.g., to exert cytotoxic activity against a target cell) or to continue migration. A central feature of T cell biology is therefore their ability to transit from a highly motile to a stationary phenotype, i.e., from vigorous scanning to firm adhesion. Decision-making of whether to "stop" or to "go" is probably most critical in lymphoid tissue, such as peripheral lymph nodes (PLNs), where T cells move with highest speeds and are therefore only in short contact with pMHC-presenting dendritic cells (DCs). In fact, it has been estimated that each DC is contacted by \~500--5000 T cells per hour, mostly for less than a few min ([@B10], [@B11]). This raises two questions: first, how is the T cell motility induced in lymphoid tissue, and second, which factors influence T cell decision-making for fast arrest?

Regulation of T Cell Motility in Lymphoid Tissue {#S2}
================================================

The PLN parenchyme consists of a sponge-like network of loosely spaced fibroblastic reticular cells (FRCs) expressing the promigratory chemokines CCL19 and CCL21, ligands for the CCR7 chemokine receptor present on naïve T cells ([@B12]). DCs are closely attached to the FRC network to facilitate their continuous scanning by T cells ([@B13]). Furthermore, the LFA-1 ligands ICAM-1 and ICAM-2 are expressed on both DCs and FRCs, while CCL21 is deposited on DCs ([@B14], [@B15]). 2PM imaging experiments have shown that CCR7 ligands and LFA-1--ICAM-1 interactions contribute to basal migration, although even in their absence, T cells retain their amoeboid migration mode and attain considerable average speeds of \~10--12 μm/min ([@B16]--[@B19]). In line with these observations, T cells lacking the Gαi2 subunit acting downstream of CCR7 move only slightly slower than WT T cells in PLN parenchyme ([@B20]). Chemokines and integrins induce T cell polarization and the formation of a leading edge and uropod as a result of multiple signaling cascades revised elsewhere ([@B21]--[@B24]). In brief, continuous Rac-mediated F-actin assembly at the leading edge, or lamellipodium, provides the protrusion force in 3D environments, even in the absence of integrin ligands ([@B25]). This is reflected in T cells lacking the DOCK2 guanine exchange factor for the small GTPase Rac1 and 2. These cells display strongly impaired *in vitro* motility ([@B26]), and similar to Rac1/2-double-deficient T cells, show virtually no residual migration in PLN parenchyme ([@B27], [@B28]). Thus, LFA-1, CCR7, and other, as of yet unknown factors lead to DOCK2--Rac-driven T cell motility. The importance of this pathway for host surveillance is underscored by the recent identification of DOCK2-deficient patients, who suffer from early onset severe invasive infections ([@B29]).

Furthermore, lysophosphatidic acid (LPA) produced by the exoenzyme autotaxin (ATX) on stromal cells, including high endothelial venules (HEVs) and FRCs, contributes to transmigration and basal lymphocyte motility in PLNs ([@B30]--[@B34]). LPA binds to T cell-expressed LPA2, a member of the GPCR family, and induces Rho activation, which cooperates with CCL21 to induce contractility-dependent lymphocyte migration. Pharmacological blocking of ATX or LPA receptors or lack of LPA2 reduces T cell speeds by \~30% *in vivo*, while addition of LPA increases T cell polarization and speeds *in vitro* ([@B30], [@B31], [@B33]). These observations are in line with recent descriptions of increased cell motility generated by augmented contractility of the trailing edge in confined environments ([@B35], [@B36]). Similarly, T cells crossing endothelial barriers is facilitated by the Rho-GTP effector ROCK and Myosin IIA-mediated contractility to move the nucleus through narrow pores and for detachment of LFA-1--ICAM-1 adhesions ([@B25], [@B37], [@B38]). Finally, *in vitro* and *in vivo* experiments support a role for tyrosine kinase signaling downstream chemokine receptor signaling in T cells. Thus, inhibition with Janus kinases (JAK) prevents T cell chemotaxis to CCL21, adhesion to HEVs and homing ([@B39]--[@B41]). Of note, interstitial motility within lymphoid tissue was not affected by the absence of JAK1 and JAK2, pointing to compensatory mechanisms that ensure robust motility.

Dynamic Control of T Cell Arrest {#S3}
================================

Ground-breaking work by Dustin and colleagues has uncovered that *in vitro* generated chemotactic gradients, including the prototypic T cell-attracting chemokine CCL21, are capable to disrupt TCR--pMHC complexes, leading to detachment from antigen-presenting cells and blunted T cell activation ([@B42], [@B43]). Although CCL21 gradients have been confirmed in interfollicular regions of PLNs ([@B44]), it remains unclear whether such gradients exist in the paracortical T cell zone or around HEVs, where naive T cells first encounter DCs ([@B45]). Interestingly, mice lacking promigratory CCR7 ligands show a delayed but ultimately enhanced T cell responses during immune responses ([@B46]). The delayed onset may result from lack of efficient T cell--DC encounters at early time points, while exceeding T cell responses at later time points are consistent with an immunosuppressive action of CCL21 via disruption of weakly reactive T cell -- DC interactions.

Two photon microscopy analysis has helped to subdivide T cell--DC interactions into distinct phases that are regulated by surface levels of pMHC on DCs, as well as the TCR--pMHC affinity. Thus, high levels of cognate pMHC are able to induce immediate arrest of reactive T cells, whereas low levels result in a continuous scanning behavior of T cells ([@B47]--[@B49]). During scanning, which can last up to 8 h and is referred to as "phase 1," T cells are able to summate signals through active NFAT and c-fos signaling ([@B50], [@B51]). In addition to pMHC, ICAM-1 on DCs facilitates T cell arrest ([@B52]), whereas regulatory T cells (Tregs) prevent stable interactions with DCs in this phase ([@B53], [@B54]). "Phase 2" stable T cell--DC interactions last for several hours and are commonly thought to be critical for full T cell activation through the formation of an immunological synapse (IS). Thus far, the precise duration of individual stable T cell--DC contacts has proven difficult to assess *in vivo*, owing to technical limitations maintaining physiological conditions and the identical field of view during intravital imaging. After \~20 h post T cell transfer, activated T cells resume motility and detach from DCs before committing to cell division, in the so-called phase 3 (Figure [1](#F1){ref-type="fig"}A).

![**Motile T cell--DC interactions in lymphoid tissue**. **(A)** Phases of interactions between pMHC-loaded DCs and T cells after their entry into lymph nodes. Phase 1 is characterized by transient interactions, whereas T cells engage stably with DCs during phase 2. In phase 3, T cells detach from DCs and begin to divide before egressing as effector T cells. Adapted from Ref. ([@B55]). **(B)** Regulation of weak T cell--DC interactions by TXA2 secretion. TP-induced motility prevents stable T cell attachment (phase 1--2 transition) unless a critical pMHC threshold is presented on DCs, thus ensuring a high quality of ensuing CD4^+^ T cell responses. **(C)** Secretion of CCR5 ligands CCL3 and CCL4 by pairs of interacting CD4^+^ T cells and DCs attract naïve CD8^+^ T cells and helps to foster CD4^+^ T cell help. By contrast, excessive CCR5 ligand production in the absence of Tregs deteriorates the quality of CD8^+^ T cell responses by allowing weakly interacting clones to attach to DCs.](fimmu-06-00559-g001){#F1}

Early *in vitro* evidence suggests that decision-making leading to arrest on DCs may require only a few seconds and correlates with induction of Ca flux in responsive T cells ([@B56], [@B57]). Interestingly, dynamic DOCK2-driven F-actin assembly at the leading edge of motile T cells is maintained during interactions with DCs, but with a different spatial arrangement at the IS interface. TCR signaling and ICAM-1--LFA-1-mediated adhesion convert Rac-driven protrusion activity at the lamellipodium of migrating T cells into an annular F-actin ring with centripetal directionality at the IS interface ([@B58], [@B59]). Combining these *in vitro* observations with 2PM data, the decision-making of motile T cells to undergo conversion from translocation to arrest requires a threshold pMHC level on DCs, sufficient integrated signals from previous DC encounters and LFA-1-mediated firm adhesion. Weak activatory signals because of low pMHC levels, low TCR--pMHC affinity or lack of ICAM-1 on DCs would be insufficient to trigger F-actin conversion to a ring-like structure. Consistent with this model, inhibitory receptors of TCR signaling including CTLA-4 and PD-1 prevent T cell adhesion to antigen-presenting cells ([@B60]--[@B62]).

Recent work by Krummel and colleagues has shown that naïve T cells express Myo1g, a regulator of membrane tension. When T cells are exposed to physical pressure, Myo1g accumulates at the spot of pressure exertion, followed by adjacent generation of a newly formed F-actin protrusion ([@B63]). *In vitro* and *in vivo* assays uncovered that Myo1g activity results in a meandering migration pattern, since Myo1g-deficient T cells showed less turning behavior and higher directionality. As a result, Myo1g-deficient T cells displayed shorter interaction times with DCs *in vivo*, as the average scanning time decreased from \~1.7 to 1 min. This reduced interaction time had a significant impact for T cell engagement with rare DCs, since Myo1g-deficient T cells were unable to "read" enough DC activation signals for arrest conversion and maintained their migratory behavior ([@B63]). In sum, *in vivo* migrating T cells need a minimal DC scanning time of \~100 s to integrate sufficient TCR signals for a successful conversion of protruding to annular F-actin and IS formation. This process is supported by LFA-1 adhesion to ICAM-1 on DCs.

Thromboxane A2-Induced Motility as Quality Control for CD4^+^ T Cell Responses {#S4}
==============================================================================

Activated DCs increase surface expression of costimulatory molecules and are therefore able to efficiently activate T cells, including weakly reactive or potentially self-reactive clones. Work by Sanui and colleagues has identified activated DCs and macrophages as important source of thromboxane A2 (TXA2). TXA2 is a secreted lipid with short half-life that binds the Gα12/13-coupled TP receptor expressed on naïve but not effector/memory T cells. Binding of TXA2 to TP induces lsc (also known as p115 RhoGEF or ArhGEF1)-mediated Rho activation ([@B64]), which induces chemokinetic motility *in vitro* and disruption of T cell--DC pairs ([@B65]). In a recent study, TXA2 was shown to specifically thwart the activation of weakly reactive CD4^+^ T cell clones. After immunization or infection, Ag-specific CD4^+^ T cells that bound tetramers only weakly expanded significantly more in the absence of TP. Using 2PM imaging of reactive PLNs, the absence of TP on naïve CD4^+^ T cells resulted in increased interactions with DCs presenting low amounts or weak agonist pMHC, leading to a premature phase 1 to phase 2 transition and excessive T cell expansion (Figure [1](#F1){ref-type="fig"}B). By contrast, WT- and TP-deficient CD4^+^ T cells similarly engaged with DCs presenting high amounts of agonist pMHC, indicating that TXA2 preferentially prevents arrest of weakly reactive T cell clones ([@B66]). Thus, TXA2 allows T cells to maintain their search for DCs presenting high levels of cognate pMHC, rather than weak agonist or self-peptides. Indeed, TXA2-mediated quality control of early T cell--DC interactions prevented the excessive generation of follicular helper cells, which provide help to weakly reactive germinal center B cells. As consequence, lack of TXA2--TP signaling during T cell priming deteriorated the overall quality of the ensuing immune response ([@B66]).

Tightly Regulated CCR5 Ligand Expression Controls the Quality of CD8^+^ T Cell Responses {#S5}
========================================================================================

A comparable link between the quality of adaptive immune responses and low affinity-driven interactions was made when examining how the absence of Tregs affected CD8^+^ T cell engagement with DCs. Previous work had shown that baseline production of CCR5 ligands CCL3 and CCL4 leads to the recruitment of naive CD8^+^ T cells to DC engaged in productive interactions with CD4^+^ T cells, resulting in CD4^+^ T cell help and effective CD8^+^ T cell memory formation ([@B67]). By contrast, in the absence of Tregs, DCs produced increased amounts of CCR5 ligands that facilitated excessive engagement of CD8^+^ T cells with DCs presenting low-affinity pMHC complexes as assessed by 2PM imaging (Figure [1](#F1){ref-type="fig"}C). This resulted in an overall lower quality of the adaptive immune responses, since the ratio of low versus high avidity clones was shifted towards the former population ([@B68]). Thus, similar to TXA2, motility-inducing agents influence T cell--DC interactions inside reactive PLNs that contain highly stimulatory DCs. It is interesting to note that in non-reactive PLNs, the absence of CCR5 ligand production and TXA2 permits unbiased scanning of resident DCs by naïve T cells, which is essential for efficient peripheral tolerance education.

Concluding Remarks {#S6}
==================

Two photon microscopy-based investigation of T cell--DC interactions has uncovered factors that, in addition to pMHC abundance and affinity, regulate the dynamic interplay between these two cell types. Although tightly regulated T cell attraction to activated DCs promote adaptive immune responses by allowing rare cells to meet, excessive interactions with low-affinity pMHC-presenting DCs deteriorate the overall quality of clonal expansion. Furthermore, intrinsic wiring of the migratory behavior of T cells facilitates their scanning function. Thus, programmed Myo1g-induced meandering behavior permits sufficiently long interactions between T cells and DCs. In addition, continuous F-actin treadmilling during both migration and IS formation endows T cells with the capacity to quickly switch between migratory versus stationary modes. Thus, upon cessation of TCR signaling, T cells resume their motility, presumably to avoid overstimulation and to prepare for egress. These observations raise new interesting questions. For example, is the duration of phase 2-like stable interactions regulated by external chemoattractant gradients or cell-intrinsic mechanisms? Furthermore, desensitization of chemokine receptors, such as CCR5, and its impact on T cell motility patterns *in vivo* has not been investigated in detail. Such studies are relevant since CCR5 ligands attract cognate and non-cognate naïve CD8^+^ T cells, and would rapidly limit access to DCs unless CCR5 desensitization is allowing cell turnover. The continued examination of mechanisms that control T cell motility in lymphoid tissue and their impact on adaptive immune responses will remain a productive field of research in years to come.
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